Subcellular Mass Spectrometry Imaging and Absolute Quantitative Analysis across Organelles by Thomen, Aur\ue9lien et al.
Subcellular Mass Spectrometry Imaging and Absolute Quantitative
Analysis across Organelles
Downloaded from: https://research.chalmers.se, 2020-07-11 06:45 UTC
Citation for the original published paper (version of record):
Thomen, A., Najafinobar, N., Penen, F. et al (2020)
Subcellular Mass Spectrometry Imaging and Absolute Quantitative Analysis across Organelles
ACS Nano, 14(4): 4316-4325
http://dx.doi.org/10.1021/acsnano.9b09804
N.B. When citing this work, cite the original published paper.
research.chalmers.se offers the possibility of retrieving research publications produced at Chalmers University of Technology.
It covers all kind of research output: articles, dissertations, conference papers, reports etc. since 2004.
research.chalmers.se is administrated and maintained by Chalmers Library
(article starts on next page)
Subcellular Mass Spectrometry Imaging and
Absolute Quantitative Analysis across
Organelles
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ABSTRACT: Mass spectrometry imaging is a field that
promises to become a mainstream bioanalysis technology by
allowing the combination of single-cell imaging and subcellular
quantitative analysis. The frontier of single-cell imaging has
advanced to the point where it is now possible to compare the
chemical contents of individual organelles in terms of raw or
normalized ion signal. However, to realize the full potential of
this technology, it is necessary to move beyond this concept of
relative quantification. Here we present a nanoSIMS imaging method that directly measures the absolute concentration of an
organelle-associated, isotopically labeled, pro-drug directly from a mass spectrometry image. This is validated with a recently
developed nanoelectrochemistry method for single organelles. We establish a limit of detection based on the number of
isotopic labels used and the volume of the organelle of interest, also offering this calculation as a web application. This
approach allows subcellular quantification of drugs and metabolites, an overarching and previously unmet goal in cell science
and pharmaceutical development.
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The concentration of metabolites and drugs in bio-logical matrices is the principal read-out in the fields ofmetabolomics and pharmacokinetics. However, the
typical format of these matricesbiofluids, tissue, and cell
lysatesis not sufficient to further our understanding of
biochemistry, particularly at the level of the single cell or
organelle.1−3 While the cell is the basic unit of life, metabolic
and disease-associated pathways are regulated at the subcellular
level. Thus, it is important to measure concentrations of
relevant molecules in subcellular compartments in order to
better understand and modulate the biochemical environment
of the intact cell.4−7
One contemporary method of visualizing subcellular
domains is mass spectrometry imaging.2,8 Mass spectrometry
imaging has been increasingly applied to investigate the
organization of different biomolecules for fundamental studies
of cell biology as well as in pharmaceutical and medical
research. This bioimaging approach could be made even more
powerful if it were possible to apply it to absolute
quantification of biomolecules at the nanoscale level. Although
approaches to absolutely quantify concentrations of metabo-
lites and drugs at the nanoscale with mass spectrometry
bioimaging are broadly important, this has remained a
neglected area in the field3 owing to several substantial
challenges, of which the major ones are a lack of appropriate
standards and limited complementary techniques.
Nanoscale secondary ion mass spectrometry (nanoSIMS)
imaging, in particular, offers an incredible opportunity here as
Steinhauser and Lechene have previously articulated. The
advantages are as follows: (i) the use of nontoxic labels, (ii)
high spatial resolution, and (iii) the ability to quantify down to
as low as 1 ppm over a wide dynamic range.9,10 These
advantages have been exquisitely demonstrated by several
groups who have shown subcellular distribution of drugs and
metabolites in the context of the intact cell.11−17 Importantly,
relative quantification18 has also been demonstrated at the
subcellular level. For example, in an adipocyte model it was
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possible to quantify the amount of 13C-labeled fatty acid
transferred from the extracellular space to cytoplasmic lipid
droplets.19 This was done by assuming that the percentage 13C
enrichment of each region could be scaled to the known 13C
concentration of the incubation media. Relative quantification
of exogenous isotopically labeled fatty acids and cholesterol has
also been demonstrated by direct comparison of isotopic
ratios, with added spatial resolution provided by back
scattering electron microscopy.20−22 Additionally, incorpora-
tion and subsequent redistribution of an 15N-labeled nucleo-
side was tracked by imaging segregation of chromosomes
during stem cell division. A relative comparison of isotopic
ratios from labeled cells showed that the nucleosides were
distributed randomly in stem cells.23 These previous works
clearly show the enormous utility of carrying out subcellular
measurements using nanoSIMS; however, all used relative
quantification.
To assess more accurately the intracellular concentrations of
drugs and metabolites, several methods have been developed
that can be used to estimate the concentrations of compounds
partitioned at the subcellular level.5−7 However, these methods
rely on the perturbation of intact cells and tissue, and it is
extremely difficult to gauge how these perturbations affect the
measurement. The challenge in evaluating subcellular concen-
tration in drug discovery, specifically for drug exposure at
intracellular targets, is illustrated by the fact that 60% of the
targets for FDA approved drugs are located on the cell
membrane, where only 22% of proteins encoded in the human
genome are found.24 This highlights that there is a critical
opportunity beyond the cell membrane to access important
therapeutic targets. Indeed, there is an increasing effort in drug
discovery toward intracellular drug targets.4
To overcome the major challenges inherent in carrying out
absolute quantitative imaging, an ideal standard consisting of a
known amount of the analyte incorporated into the same
matrix under investigation, termed “matrix matched”, should
be used.25 For example, in the semiconductor industry known
amounts of a dopant are implanted into the material of
interest,26 whereas geologists utilize minerals from nature with
well-characterized chemical compositions.27 In principle one
can use a combination of both of these approaches to arrive at
an isotopic ratio to concentration conversion.
In this work, we have set out to achieve absolute versus
relative quantification of carbon species in subcellular mass
spectrometry imaging. The foundation of this work is that a
standard procedure for sample preparation of cells and tissues
for nanoSIMS is to embed the biological material in epoxy. We
have herein determined that epoxy is well matched to the cell
biomass in terms of carbon concentration. This allows the use
of a material science approach where we treat the entire
embedded biomass as a matrix under analysis. Furthermore, we
complement our measured concentration using a well-
characterized biological system. Recently, the Ewing lab has
devised an electrochemical method to quantify the electro-
active content of individual secretory vesicles in situ in an
individual cell. Since this measurement is performed in the
correct biological context, the result is a more accurate
representation of the real concentration contained within the
vesicles8,28,29 and provides the necessary complementary
approach for validation, albeit on an ensemble of vesicles
where there is no imaging or individual sizing. Using
nanoSIMS, we show that it is possible to determine a validated
concentration of a pro-drug-derived compound at subcellular
spatial resolution. This approach, validated with electro-
chemistry, is applicable to imaging a broad range of
nonelectroactive as well as electroactive substances in specific
identifiable organelles.
RESULTS AND DISCUSSION
Definition of the Material (Resin-Embedded Cells).
The approach that we explored here was to treat the biological
sample as a carbon material composed of a mixture of three
components. Figure 1a shows the basic concept of a cell pellet
embedded in epoxy resin; the pellet is then sectioned to a
thickness between 300 nm and 1 μm as depicted in Figure 1b.
Here, the three carbon-containing components are indicated as
follows: yellow shows the epoxy resin, black is the biomass, and
green shows the 13C-labeled drug or metabolite. In Figure 1c,
we deconstruct the three carbon-containing components and
emphasize that only the 13C-labeled drug or metabolite
contributes to isotopic enrichment. Applying this model to
the measurement of isotopic ratio, a measurement acquired
from a part of the section outside of the cell material, exosomes
or cellular debris, will reflect the isotopic ratio of the epoxy,
while a measurement from inside the cell will reflect the
isotopic ratio of the mixture of the epoxy and the biomass. We
assume that the epoxy replaces all the water in the cell, and
thus the majority of the carbon contributing to the intracellular
isotopic measurement is derived from the epoxy since the cell
consists of 60−70% water. Finally, any isotopic measurement
of the 13C-labeled drug-metabolite-containing organelle will
consist of all three components. The key to using this model
for quantification lies in the ability to determine the
contribution of each component, thus allowing the contribu-
tion of the 13C-labeled drug to be converted to a
concentration.
Figure 1. Three-component resin-embedded cell material. (a)
Schematic of a resin-embedded cell pellet. (b) Schematic of a 300
nm to 1 μm thick section from a resin-embedded cell pellet. (c)
Deconstruction of the three major carbon sources of the resin-
embedded cell material: the epoxy, the biomass, and the 13C-
labeled drug or metabolite, where the epoxy and the biomass have
no enrichment in 13C and where the labeled drug will introduce
13C enrichment.
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Optimization of NanoSIMS Parameters for the Resin-
Embedded Cell Material. The first step toward under-
standing the relative contributions of the three-component
system was to investigate carbon ion emission across individual
resin-embedded cells. In order to make a precise isotopic
measurement, one must consider mass resolution slit settings
and transmission (see NanoSIMS Parameters), but potentially
the most important requirement was that the secondary ion
emission had to reach a steady state. We found that variations
in the isotopic ratio in the transient state could be greater than
50‰. Figure 2 shows that a steady state in ion emission begins
as the fluence approaches 1 × 1017 Cs+·cm−2. Thus, to ensure a
high precision isotopic measurement of this material,
implantation of 1 × 1017 Cs+·cm−2 was carried out before
analysis.
Characterization of Resin-Embedded Cell Material.
Using the optimized nanoSIMS parameters it was possible to
routinely obtain images of resin-embedded cells, such as the
example of a rat pheochromocytoma (PC12) cell shown in
Figure 3. The primary observation here is that the C2
− signal
(Figure 3a) shows very little contrast between the epoxy and
the cell region (epoxy + biomass) as compared to the CN−
signal shown in Figure 3b. To further characterize this
observation, we analyzed the ion yield of C2
− and CN−
relative to the frequency of the arrival of Cs+ ions, in other
words the number of C2
− or CN− ions measured for every Cs+
delivered to the surface. For all measurements in Figure 3c, the
C2
−/Cs+ ratios vary from 0.021 to 0.028 cps/cps within the
16−84% interval The specific regions in the image had similar
ranges of 0.023 to 0.027 for epoxy regions, 0.021 to 0.029 for
cytoplasm regions, 0.021 to 0.029 for the nucleus, and 0.021 to
0.031 for the dense regions in the nucleus that indicate the
nucleolus. In contrast, Figure 3d shows that the CN−/Cs+ for
all regions spans a wide range from 0.0008 to 0.015, while the
yields from the specific regions scale with the inclusion of the
embedded cell biomass. Thus, the lowest yield is from the
epoxy, between 0.00075 and 0.00098, and the highest yield
(0.015 to 0.0184) was measured in the nucleolus region, which
logically contained a higher amount of biomass. It was found
that while the biomass displaced the pure epoxy enough to
increase the yield of CN− 20 times, the displacement did not
greatly affect the ion yield of C2
−. The observation that the
12C2
− emission from the cell was similar to the 12C2
− emission
from the collective epoxy and biomass mixture supports the
idea that the concentration of carbon in the resin-embedded
cell material can be treated as a uniform carbon matrix
containing areas of 13C-labeled drug-metabolite enrichment.
To determine if the comparable C2
− ion emission resulted
from an equimolar carbon concentration between the bio-
logical material and the resin, we carried out elemental analysis
of both the epoxy resin (AGAR 100) and the biomass of the
PC12 cells. The pie charts in Figure 4 demonstrate that the
proportion of carbon is in fact quite similar, and when
corrected for the density of each material, we find that each
component has between 51.6 and 55.5 M carbon (see
Supporting Information). Thus, the relative amount of each
material does not greatly affect the general carbon density of
the resin-embedded cell material, consistent with the
uniformity we observed from the nanoSIMS image. However,
in light of the fact that the two components are not identical,
we refined the value to 54 M C by assuming a 70:30 ratio
epoxy to biomass based on the approximate water content that
was replaced by the epoxy. This greatly simplified the
approach, as it was appropriate to treat this material as a
two-component material, specifically a 54 M carbon concen-
tration in the combined epoxy and biomass material,
containing a trace amount of a 13C-labeled drug-metabolite.
Thereafter, the enrichment from a 13C-labeled drug-metabolite
was scaled relative to the 54 M carbon from the resin-
embedded cell material to arrive at an absolute concentration.
Figure 2. 12C14N−, 12C2
−, and 28Si− secondary ion count rates and
δ13CVPDB vs Cs
+ ion dose. During the first part of sputtering, the
transient state (0 to 1017 Cs+·cm−2, from 0 to ∼180 nm depth), the
sputtering rate changed. At steady state (>1017 Cs+·cm−2, >∼180
nm depth) the sputtering rate was constant, and it is in this region
where measurements were performed until reaching the silicon
wafer. Vpdb stands for the Vienna Pee Dee Belemnite standard.
Figure 3. Submicrometer scale variation in carbon signal. (a)
Secondary ion image of 12C2
−. (b) Secondary ion image on CN−
across the resin-embedded cell material, scale in counts per second
(Cps). (c) Box plots of C2
−/Cs+ ratios measured across several
regions for n = 5 embedded cells. (d) Box plots of CN−/Cs+ ratios
measured across several regions for n = 5 embedded cells.
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The elemental analysis was also used to determine the
atomic ratio of H:C for each component. The atomic ratio of
hydrogen to carbon has been shown to influence matrix
ionization effects. Specifically, the matrix effect for δ13C in
organic material varies with a systematic error of 4‰ from
graphite to highly aliphatic materials spanning a range of H:C
ratios from 0 to 1.7.27 The epoxy and biomass give H:C ratios
of 1.4 and 1.7, respectively. Over this range the systematic
error is comparatively low when considering the precision of
the nanoSIMS measurement (5−10‰).
Calculation of the Fraction of 13C-Labeled Drug or
Metabolite in the Resin-Embedded Cell Material. Figure
1 shows that the 13C/12C ratio measured in a given region of
interest (ROI) represents a mixture of the three components in
various proportions (epoxy, biomass, and 13C-labeled drug/
metabolite). The proportions of each component are linked to
the isotopic ratio by a simple formula (eq 1), where each term
(13/12Ccomponent) is the number of
13C or 12C isotopes in a given
component.
C
C
C C C
C C C
13
ROI
13
epoxy
13
biomass
13
drug.met
13
epoxy
12
biomass
12
drug.met
12=
+ +
+ + (1)
After rearrangement of the equation above, the fraction of
the 13C-labeled drug-metabolite ( fdrug.met) is defined as the
number of 12C contributed by the drug-metabolite divided by
the total number of 12C. It is preferred to express fdrug.met in
terms of 12C because it allows the ratios to be expressed in the
standard form as a function of 13C/12C (see Supporting
Information, part S2). Additionally, and as shown in Figure 1,
the value of 13C/12Cepoxy is equal to
13C/12Cbiomass and
therefore collapsed into a single term, which was defined as
the control. Thus, fdrug.met is determined from the ratio
measured from the ROI minus the ratio of the control divided
by the true ratio of the drug-metabolite again minus the ratio
of the control (eq 2). The true ratio of the drug-metabolite is
obtained from the chemical formula. In the following
experiments, 13C6-dopamine was used (Figure 5d), which
contains six 13C and two 12C atoms; thus for 13C6-dopamine,
fdrug.met is equal to 3.
f
C
C
C
C
C
C
C
C
C
C
drug.met
drug.met
12
total
12
13
ROI
12
13
control
12
13
drug.met
12
13
control
12
= =
−
−
(2)
We simplified this expression by introducing the deviation of
the isotopic ratio, δ13C, in parts-per-thousand or per mille (‰)
relative to a reference. By convention, the reference is the
Vienna Pee Dee Belemnite (VPDB) where rVPDB is equal to
0.0112372.31 This allows fdrug.met to be calculated by the
product of the measured enrichment and a constant
determined by the ratio of VPDB to the true ratio of the drug.
f
C C r
r
( )
1000drug.met
13
VPDB
ROI 13
VPDB
epoxy
VPDB
drug.met
δ δ= − ×
× (3)
Here, rdrug.met is the isotopic ratio
13C/12Cdrug.met of the
13C-
labeled drug/metabolite. To extract the absolute concentration
from fdrug.met, we used our measurement of the homogeneous
carbon density of 54 M in the resin-embedded cell material
and that the concentration of the drug is relative to the number
of 12C atoms in the drug-metabolite. This produces the simple
relationship in eq 4, where the [drug_met] in mol/L is
expressed as
f
C
drug. met
54Mdrug.met
drug.met
12[ ] =
×
(4)
Substituting the equation for fdrug.met in eq 1 into eq 4, the
concentration in moles per liter from the measurements in per
mille is obtained in eq 5. We note here that this substitution
cancels the 12Cdrug.met term making
13Cdrug.met the relevant value.
C C
C
drug. met
( )
1000
VPDB 54M13 VPDB
ROI 13
VPDB
control
drug.met
13
δ δ[ ] = − × ×
(5)
For the specific case of dopamine in secretory vesicles, we
input the number of 13C labels on the molecule where the
enrichment is scaled using a constant (0.101) as shown in eq 6.
C CDopamine ( ) 0.10113 VPDB
ROI 13
VPDB
controlδ δ[ ] = − × (6)
This expression shows that a carbon concentration of 54 M
gives a 13C concentration of 0.606 M when standardized to
VPDB, which is divided by 6 to account for the 6 13C atoms
per drug molecule to finally give a factor of 0.101 for 13C6-
dopamine. The concentration of the drug or metabolite, in the
case of dopamine, can be expressed as the simple relationship
where the difference between δ13CROIVPDB and δ
13CcontrolVPDB in
per mille is scaled by a factor that represents the concentration
of 13C in the resin-embedded cell material divided by the
number of 13C atoms in the drug or metabolite.
Quantification of 13C-Labeled Dopamine in PC12 Cell
Vesicles. A two-dimensional isotopic image compiled from 50
planes through a PC12 cell is shown in Figure 5a. This image
represents the δ13C in per mille, showing clearly that the 13C
dopamine has been loaded into the PC12 cell vesicles via the
vesicular monoamine transporter. To convert the enrichment
to a concentration, we had to consider that the vesicle
diameters are generally smaller than the thickness of the
section. The two-dimensional accumulation image was there-
fore found to be cumbersome to use for a quantitative
measurement, as it is impossible to accumulate a number of
planes that could accommodate all the vesicles under
Figure 4. Elemental analysis of Agar100 epoxy resin and PC12
biomass. Elemental analysis and density, ρ, of AGAR 100 epoxy
and PC12 biomass showing the contribution from each
component. C, carbon; O, oxygen; S, sulfur; H, hydrogen content.
(*Oxygen content was inferred for both materials, see Supporting
Information 1 and 2, while the **biomass density was not
measured but obtained from the literature.30)
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investigation. Accumulation of planes ultimately created a
dilution effect, leading to an underestimation of the
concentration. Indeed, using this method we find the
concentration of 13C6-dopamine is 30 ± 9 mM (Supporting
Information Table S2 and Figure S2). To demonstrate this
further, we compared the image to the depth profiles
representing the 28 vesicles (Figure 5b). The concentration
of the 13C-dopamine was calculated at different planes using eq
6, which is also displayed in Figure 5c. Here, we found that the
maximum values in depth were as much as double the maxima
found in the accumulated image. We also found the profiles
were both symmetric and asymmetric, thus indicating a
partitioning of the 13C-dopamine. In addition, Figure 5d
presents surface plots where the appropriate planes for each
vesicle were accumulated based on the depth profiles from
Figure 5b. These plots show that the peak values, over a range
of 20−80 mM 13C-dopamine, did not distribute evenly across
the vesicle, but instead formed a concentration gradient where
there is an accumulation at a hot spot, thought to be the
location of the protein dense core, inside the vesicle. This is
also supported by our previous findings.11
Validation of Quantification of 13C-Labeled Dopa-
mine in PC12 Cell Vesicles. The secretory vesicles of PC12
cells are an ideal model to validate this method, as they are
structures at the 100 nm scale containing a high concentration
of dopamine and are suitable for quantitative nanoSIMS
imaging at high spatial resolution. Most importantly, the
concentration of catecholamine in nanometer vesicles can be
calculated with electrochemistry to determine the molecular
quantity in individual vesicles32,33,36 divided by a mean
vesicular volume. This provides a benchmark by which to
validate our quantitative nanoSIMS approach. Electrochemical
experiments indicate that while the number of molecules per
vesicle can vary, especially following L-DOPA treatment, the
concentration is largely conserved, presumably due to a
swelling of the vesicle to accommodate a larger number of
Figure 5. Quantification of 13C-labeled dopamine in PC12 cell vesicles. (a) δ13C image of a single PC12 cell, which has undergone
transporter-mediated uptake of 13C6-dopamine. (b) Depth projection of 28 ROIs indicated in (a). (c) A version eq 6 that displays the value
of the 13Cdrug.met term is shown with the
13C6-dopamine molecule. (d) 28 vesicle images plotted with concentration on the z axis.
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molecules.34 The box plots in Figure 6b show the comparison
between electrochemical measurements36 and the nanoSIMS
measurements presented in Figure 5. To make this
comparison, we needed to define the perimeter of the vesicle
so as not to underestimate the concentration. The small size of
the vesicle makes this challenging. Specifically, the diameter of
the Cs+ analysis beam is comparable to the diameter of the
vesicle, making it virtually impossible to avoid some degree of
dilution associated with the primary ion source, known as
beam mixing. Thus, we defined four regions as illustrated in
Figure 6a. From the depth profile we averaged the values at
50%, 75%, and 90% of the maximum and took the value at the
maximum. Although the mean concentration trends upward
for these cross sections, as we move from 50% to the maximum
in order to minimize the contribution of beam mixing (Figure
6b), the values are not statistically different from the spread in
the averaged concentrations found using electrochemistry.
Furthermore, a histogram of vesicle number versus concen-
tration (Figure 6c) shows clear overlap between the methods
(histograms of nanoSIMS data for the other values are shown
in the SI, Figure S3). It is important to realize that there is a
range of vesicle content between different PC12 cell
populations, and we are well within this range. We further
sought to minimize beam mixing by analyzing the same
vesicles using a standard and a reduced diameter ion probe. By
reducing the D1 aperture from 200 μm (D1_3) to 100 μm
(D1_5) the primary current can be reduced by a factor of 4 to
provide a smaller albeit less intense primary ion beam. We
present images in Figure S4a and S4b to show that, in addition
to the increased spatial resolution, the vesicle signal is more
intense when using a reduced probe size. When comparing the
individual vesicles, we find that in all cases the higher
resolution vesicle measurements give a higher value (Figure
S4c), indicative of a reduction in beam mixing. This is also
shown with box plots for the mean values in Figure S4d, where
the standard probe ROIs have a median value of 30.5 mM with
a range from 17 to 39 mM. This is similar to the value
measured for the accumulated images (as shown in Figure S2)
measured under identical comparable conditions. The reduced
probe, by comparison, shows a median value of 53.5 over a
spread from 47 to 81 mM and is similar to the results found for
the maximum values extracted from the depth profile and the
electrochemical measurement. The intensive property of the
nanoSIMS measurements shows that it directly measures the
concentration of dopamine and does not rely on subsequent
estimation of the vesicle volumes.
Detection Limit of 13C-Labeled Drugs and Metabo-
lites. To this point, we have discussed measuring absolute
concentrations of drugs or metabolites in cellular nanostruc-
tures. An important consideration of any concentration
determination is, what is the lower detection limit? The
detection limit of the drug/metabolite in a given volume is
defined here simply as its minimum detectable enrichment
within a 16−84% (1 sigma) confidence interval. Mathemati-
cally, the definition of a detectable enrichment is the condition
where the enrichment minus its own uncertainty ε is above
0‰ as (δ13CROIVPDB − δ13CcontrolVPDB) − ε > 0. This definition
of the detection limit is based on intrinsic measurement of the
isotopic ratio rather than the usual measurement of the
precision of extrinsic parameters, such as a relative sensitivity
factor or more generally the use of calibration curves.
The collection of the measured ions, the 12C2
− and 13C12C−
ions, counts 12C2
− and 13C12C− ion arrivals at the detectors for
a given period of time. This results in a variation in count rate
for a given ion species that follows a Poisson distribution. This
distribution appears when the ion arrivals to a detector of the
nanoSIMS are constant yet rare in time.35,36 An important
property of the Poisson distribution is its standard deviation
equals the square root of its mean. The destructive nature of
SIMS forces the assumption that the total number of collected
ions sputtered from a given volume is only measured once and
is a good estimation of the average contribution. Both the
denominator and numerator of an isotopic ratio in a given
volume have their respective uncertainties equal to the square
root of their total collected counts. The uncertainty of an
isotopic ratio is obtained by propagating the uncertainties
quadratically from the total number of counts for both the
numerator and denominator. The relative variation of the total
number of counts in the most abundant ion, 12C2
−, is negligible
in relation to the rarest events (13C12C−). As a result, the
uncertainty (ε) on the enrichment (δ13CROIVPDB −
δ13CcontrolVPDB) simply equals 1000/√(∑13C12C−) where
∑13C12C− is the total number of 13C12C− collected in a
given volume. Consequently, the larger the volume of the
sample, the lower the uncertainty.
In a homogeneous carbon material, like the embedding
epoxy, the number of 13C12C− ions sputtered away in a given
volume is always constant. The volume (VROI) in which the
Figure 6. Concentration comparisons with electrochemistry measurements. (a) Concentration depth profile showing how concentration was
determined for each percentage. (b) Box plots of the calculated concentrations from 50%, 75%, 90%, and the maximum concentration
through the depth of vesicle (n = 28 for these measurements and error bars are standard deviation), compared to spread across 84
measurements of averaged vesicle content using electrochemistry. (c) Histogram of the number of individual vesicles vs concentration at the
maximum of the depth profiles shown in Figure 5b for 13C dopamine (blue, nanoSIMS) and 84 measurements of the concentration of native
12C dopamine (red, echem).
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isotopic ratio is measured is defined by the area of the ROI and
the depth sputtered or the number of cycles selected by the
operator. In a chemically homogeneous material like the epoxy,
the depth sputtered away can be controlled by adjusting the
sputter time and primary current of a given measurement and
knowing the sputtering rate(s) of the material. The sputtering
rate of the epoxy is measured here in the steady state regime,
where it is constant (it varies by orders of magnitude in the
transient state37). As a composite parameter, the sputtering
rate is expressed as the depth excavated into the sample in
nanometers for a given unit primary ion current and time
within a unit area. The volume, VROI, is sputtered away with a
time, tROI, given in seconds within a chosen ROI with a
primary current, Ip, in pA, as shown in eq 7.
V
I t
s I tdepth area
s
area area ROIROI
p ROI
p= × =
× ×
×
= × ×
(7)
The total number of counts of∑13C12C− is simply the count
rate (Cps) of 13C12C− times the time (tROI) required to sputter
away a given volume. The∑13C12C− is expressed in eq 8 from
the volume VROI and their common factor, tROI, from eq 7.
C C t
V
s I
Cps
Cps13 12
ROI
ROI
p
∑ = × = ××
−
(8)
The uncertainty of the enrichment in 13C/12C of a given
volume is expressed in eq 9.
C C
s I
V
1000
1000
Cps13 12
p
ROI
ε ∼
∑
∼ ×
×
×−
(9)
Here, the ratio of primary current over secondary current,
Ip/Cps, is fixed for a given type of epoxy and the nanoSIMS
settings (transmission and detection). The sputtering rate is
fixed for a given material and for primary ion energy and angle
of incidence. As a consequence, again assuming that all
parameters are fixed, the uncertainty of a given enrichment
depends mainly on the analyzed volume. Then the detection
limit in mM is obtained by combining eq 6 and eq 9 to give eq
10.
s I
V
DL 101
Cps
p
ROI
[ ]∼ ×
×
× (10)
To better illustrate this concept, we have developed a web
application tool to determine the concentration detection limit
for nanometer cell applications. This tool is freely available at
http://molcat.it.gu.se. The application was developed to model
the feasibility of imaging labeled drugs and metabolites for
researchers that may not be familiar with nanoSIMS
parameters, and thus it has only three basic inputs. The
output for the app is a plot of sampling depth vs uncertainty in
concentration. Figure 7 shows how the molecular content
calculator can be used to design a 13C6-dopamine measurement
for a 200 nm vesicle. The first input is six 13C per dopamine
molecule, the diameter of the target structure is set to 200 nm,
and in this instance the section thickness entered is 300 nm.
The first 180 nm of the section will be eroded during
implantation and is plotted below the zero line. The predicted
uncertainty is plotted with respect to the remaining section
depth. Three simulated measurements are shown in Figure 7.
The first point with an uncertainty at 3 ± 2.7 mM would be
difficult to detect at the shallow depth, whereas the second at 6
± 0.9 mM would be detectable at a reasonable depth and a
higher concentration. The ideal scenario is the third measure-
ment, with a large depth and a high concentration of 10 ± 0.7
mM. However, at such a high concentration, this tool also
shows that it is not necessary to probe to such a great depth,
allowing for the estimation of the time required for a
sufficiently sensitive quantitative measurement. This shows
that even at shallow depths of under 50 nm, the detection limit
for 13C6-dopamine will be on the order of 1 mM and would be
easily detectable in vesicles at the reported concentrations of
approximately 60 mM.38
Figure 7. Detection limit calculator. Screenshot of the 13C-labeled molecular content calculator available at http://molcat.it.gu.se. The user
inputs the number 13C contained in the drug or metabolite, the diameter of the structure of interest, and the thickness of the resin-
embedded cell material. The output is an interactive plot of the predicted uncertainty in concentration with respect to the depth of the
material probed. Double clicking on the plot will produce a concentration measurement with a predicted uncertainty.
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CONCLUSIONS
The development of this approach to measure accurate
concentrations from nanoSIMS images provides several
important insights and possibilities. The first is the observation
that the epoxy used for embedding the cells under analysis is
well matched to the carbon content of the cell biomass. This is
highly useful, as the proportion of each material does not
greatly affect the concentration of carbon in the area analyzed.
This is evident from the nanoSIMS image, where there are
only slight variations in the carbon ion emission from the
epoxy relative to the embedded biomass. The decisive finding
in this work has been that the concentration measured in the
resin-embedded cell material is an accurate representation of
what is found in cell substructures before the sample
preparation. This has been verified with electrochemical
measurements, which were performed on PC12 cells and
show that the concentration of dopamine in vesicles of these
cells is found at the range of 60 mM, the same range we
measure with our quantitative nanoSIMS method. The third
point is that the limit of detection is primarily attenuated not
by ionization efficacy but rather by the background
concentration of 13C in the resin-embedded cell material.
This background is determined to be on the order of 600 mM.
Consequently, an isotopic measurement with a precision of
10‰ will translate to a limit of detection of approximately 6
mM or in the case of a molecule such as 13C6-dopamine, with
six labeled atoms, a concentration limit of detection of 1 mM.
This also shows that the utility of 13C-labeled drug-metabolites
is limited to compounds at or above this concentration, which
typically is achieved when they are highly concentrated in small
cellular structures.
The work presented here provides a template for absolute
subcellular quantitative SIMS imaging of drugs and metabo-
lites. We aim to make our approach accessible to biologists and
chemists who want to image epoxy embedded samples but are
not accustomed to nanoSIMS parameters. To this end we have
established a limit of detection based on the number of 13C
labels incorporated in the target analyte and the volume of the
structure of interest. This calculation is available in the form of
a freely available web application.
It should be noted that quantification of 13C-labeled
dopamine was feasible owing to the susceptibility of the
analyte to fixation during sample preparation. Dopamine
contains a primary amine, which is aldehyde fixable and is not
cleared away despite being a small metabolite. Thus,
optimization of sample preparation for other samples is still
important. Up to this point there has not been an accurate way
to determine the retention of analyte for a given sample
preparation method, but our results show retention is extensive
for dopamine in cellular vesicles. The approach we present to
obtain the actual concentration of small molecules in
nanometer compartments should enable quantitative experi-
ments in nanoSIMS imaging. This is an important first step
that will allow the use of nanoSIMS both for determining the
spatial distribution of drugs and metabolites in subcellular
regions and organelles and for measuring their concentration
and for spatial distribution in subcellular regions and
organelles, a critical advance needed in the areas of
pharmacokinetics and metabolomics.
METHODS
Cell Culture and L-DOPA Treatment. PC12 cells were cultured
as previously described39 and were plated in T-75 flasks coated with
collagen IV (Falcon, Fisher Scientific, Sweden) for 5−6 days to obtain
confluence (approximately 2.2 million cells/plate). The PC12 cells
were treated with stable isotope labeled L-3,4-dihydroxyphenylalanine
(L-DOPA) (99%, 13C6-dopamine, Cambridge Isotope Laboratories
Inc., MA, USA) for the nanoSIMS experiments and unlabeled L-
DOPA (Sigma-Aldrich, Sweden) for the electrochemistry measure-
ments. Both L-DOPA solutions were prepared as stock solutions in
phosphate-buffered saline, PBS (Sigma-Aldrich, Sweden), in the dark
and with a simultaneous argon purge (6.0, AGA Sweden). A final L-
DOPA solution with a concentration of 150 μM was obtained by
diluting the stock solution in warm cell media. Cells were treated for
12 h with L-DOPA. Treatments were done in an incubator at 37 °C in
a water-saturated atmosphere containing 5% CO2. The PC12 cells
were then washed two times with Dulbecco’s PBS without calcium or
magnesium (Sigma-Aldrich, Sweden), enzymatically harvested with
TrypLE Express (Gibco, Fisher Scientific, Sweden), then resuspended
in PBS before chemical fixation.
Chemical Fixation and Embedding. The PC12 cells were
incubated at 4 °C overnight in a modified Karnovsky fixative40
containing 0.01% sodium azide (BDH, UK), 1% formaldehyde
(Sigma-Aldrich, Sweden), and 1.25% glutaraldehyde (Agar Scientific
Ltd., UK). Cells were then washed with 150 mM sodium cacodylate
buffer (Agar Scientific Ltd., UK) and postfixed using 1% osmium
tetroxide (Agar Scientific Ltd., UK) at 4 °C for 2 h followed by 0.5%
uranyl acetate (Merck, Sigma-Aldrich, Sweden) at room temperature
in the dark for 1 h. Postfixation was done, as samples sometimes are
used for transmission electron microscopy, but not in this study.
Thereafter dehydration was performed using rising concentrations of
ethanol (70%, 85%, 95%, and 99.5%) followed by 100% acetone.
Embedding was done in Agar 100 resin (Agar Scientific Ltd., UK).
Sections of 300 nm to 1 μm thick were cut using a Leica EM UC6
ultramicrotome and then placed onto Formvar-coated copper grids
(FCF200F1-Cu, EMS, USA). Poststaining of the samples using uranyl
acetate and Reynolds lead citrate was performed directly on the
grids.41
NanoSIMS Parameters. The measurements were performed
using a 16 keV Cs+ beam of ∼2 pA (D1_2) and a spatial resolution of
150 nm (normal probe) or using a 16 keV Cs+ beam of ∼0.5 pA
(D1_5) and a spatial resolution of <100 nm (reduced probe). The
transmission was set up at 35% and a mass resolving power of 10 000
(CAMECA definition) to ensure proper interference separation with
an entrance slit of 15 μm width, an aperture slit of 150 μm width, and
the energy slit full open. The saturation fluence of 1017Cs+·cm−2 was
implanted prior to each measurement. ROIs were identified in the
images by manual thresholding the features of vesicles in the images
and then depth profiling to confirm.
Vesicle Impact Electrochemical Cytometry (VIEC). To carry
out VIEC, 33 μm diameter carbon fiber disk-shaped electrodes were
placed in concentrated PC12 vesicle stock solution and allowed to
stand for 10 min at 4 °C. The electrodes were then transferred to
homogenizing buffer (381 mOsm/kg, contains 0.3 M sucrose, 1 mM
EDTA, 1 mM MgSO4, 10 mM HEPES, 10 mM KCl, and cOmplete
Protease Inhibitor) for 10 min at 37 °C to record VIEC events. The
electrodes were rebeveled and reloaded with vesicles for each
experimental run. The electrochemical recording of individual
vesicular content was performed by applying a constant potential of
+700 mV (vs Ag/AgCl) to the working electrode using a potentiostat
(Axopatch 200B, Molecular Devices, Sunnyvale, CA, USA). Signals
were filtered at 2 kHz using a 4-pole Bessel filter and digitized at 10
kHz using a Digidata model 1440A instrument with Axoscope 10.3
software (Axon Instruments Inc., Sunnyvale, CA, USA). Ampero-
metric trace processing was done with IgorPro 6.22 software from
Columbia University.42 The current was filtered at 1 kHz (binomial
sm.). Peak detection was at a threshold five times the standard
deviation of the noise. Traces of peaks were inspected, and false
positives were manually rejected. Only experimental runs with more
than 20 peaks were used in the analysis in order to minimize the
variance of the means.
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Webborn, P. J. H.; Andreń, P. E. Mass Spectrometry Imaging in Drug
Development. Anal. Chem. 2015, 87, 1437−1455.
(3) Dollery, C. T. Intracellular Drug Concentrations. Clin.
Pharmacol. Ther. 2013, 93, 263−236.
(4) Hann, M. M.; Simpson, G. L. Intracellular Drug Concentration
and Disposition–The Missing Link? Methods 2014, 68, 283−285.
(5) Mateus, A.; Gordon, L. J.; Wayne, G. J.; Almqvist, H.; Axelsson,
H.; Seashore-Ludlow, B.; Treyer, A.; Matsson, P.; Lundback, T.;
West, A.; Hann, M. M.; Artursson, P. Prediction of Intracellular
Exposure Bridges the Gap between Target- and Cell-Based Drug
Discovery. Proc. Natl. Acad. Sci. U. S. A. 2017, 114, E6231−E6239.
(6) Friden, M.; Bergstrom, F.; Wan, H.; Rehngren, M.; Ahlin, G.;
Hammarlund-Udenaes, M.; Bredberg, U. Measurement of Unbound
Drug Exposure in Brain: Modeling of pH Partitioning Explains
Diverging Results between the Brain Slice and Brain Homogenate
Methods. Drug Metab. Dispos. 2011, 39, 353−362.
(7) Friden, M.; Ducrozet, F.; Middleton, B.; Antonsson, M.;
Bredberg, U.; Hammarlund-Udenaes, M. Development of a High-
Throughput Brain Slice Method for Studying Drug Distribution in the
Central Nervous System. Drug Metab. Dispos. 2009, 37, 1226−1233.
(8) Phan, N. T.; Li, X.; Ewing, A. G. Measuring Synaptic Vesicles
Using Cellular Electrochemistry and Nanoscale Molecular Imaging.
Nat. Rev. Chem. 2017, 1, 1−18.
(9) Steinhauser, M. L.; Lechene, C. P. Quantitative Imaging of
Subcellular Metabolism with Stable Isotopes and Multi-Isotope
Imaging Mass Spectrometry. Semin. Cell Dev. Biol. 2013, 24, 661−667.
(10) Hoppe, P.; Cohen, S.; Meibom, A. Nano SIMS: Technical
Aspects and Applications in Cosmochemistry and Biological Geo-
chemistry. Geostand. Geoanal. Res. 2013, 37, 111−154.
(11) Lovric, J.; Dunevall, J.; Larsson, A.; Ren, L.; Andersson, S.;
Meibom, A.; Malmberg, P.; Kurczy, M. E.; Ewing, A. G. Nano
Secondary Ion Mass Spectrometry Imaging of Dopamine Distribution
across Nanometer Vesicles. ACS Nano 2017, 11, 3446−3455.
(12) Jiang, H.; Passarelli, M. K.; Munro, P. M.; Kilburn, M. R.; West,
A.; Dollery, C. T.; Gilmore, I. S.; Rakowska, P. D. High-Resolution
Sub-Cellular Imaging by Correlative NanoSIMS and Electron
Microscopy of Amiodarone Internalisation by Lung Macrophages as
Evidence for Drug-Induced Phospholipidosis. Chem. Commun.
(Cambridge, U. K.) 2017, 53, 1506−1509.
(13) Passarelli, M. K.; Pirkl, A.; Moellers, R.; Grinfeld, D.; Kollmer,
F.; Havelund, R.; Newman, C. F.; Marshall, P. S.; Arlinghaus, H.;
Alexander, M. R.; West, A.; Horning, S.; Niehuis, E.; Makarov, A.;
Dollery, C. T.; Gilmore, I. S. The 3D OrbiSIMS-Label-Free Metabolic
Imaging with Subcellular Lateral Resolution and High Mass-Resolving
Power. Nat. Methods 2017, 14, 1175−1183.
(14) Legin, A. A.; Schintlmeister, A.; Jakupec, M. A.; Galanski, M.;
Lichtscheidl, I.; Wagner, M.; Keppler, B. K. NanoSIMS Combined
ACS Nano www.acsnano.org Article
https://dx.doi.org/10.1021/acsnano.9b09804
ACS Nano 2020, 14, 4316−4325
4324
with Fluorescence Microscopy as a Tool for Subcellular Imaging of
Isotopically Labeled Platinum-Based Anticancer Drugs. Chem. Sci.
2014, 5, 3135−3143.
(15) Lee, R. F.; Escrig, S.; Croisier, M.; Clerc-Rosset, S.; Knott, G.
W.; Meibom, A.; Davey, C. A.; Johnsson, K.; Dyson, P. J. NanoSIMS
Analysis of an Isotopically Labelled Organometallic Ruthenium (II)
Drug to Probe Its Distribution and State In Vitro. Chem. Commun.
(Cambridge, U. K.) 2015, 51, 16486−16489.
(16) Wedlock, L. E.; Kilburn, M. R.; Liu, R.; Shaw, J. A.; Berners-
Price, S. J.; Farrell, N. P. NanoSIMS Multi-Element Imaging Reveals
Internalisation and Nucleolar Targeting for a Highly-Charged
Polynuclear Platinum Compound. Chem. Commun. (Cambridge, U.
K.) 2013, 49, 6944−6946.
(17) Lee, R. F.; Riedel, T.; Escrig, S.; Maclachlan, C.; Knott, G. W.;
Davey, C. A.; Johnsson, K.; Meibom, A.; Dyson, P. J. Differences in
Cisplatin Distribution in Sensitive and Resistant Ovarian Cancer
Cells: A TEM/NanoSIMS Study. Metallomics 2017, 9, 1413−1420.
(18) Ostrowski, S. G.; Kurczy, M. E.; Roddy, T. P.; Winograd, N.;
Ewing, A. G. Secondary Ion MS Imaging to Relatively Quantify
Cholesterol in the Membranes of Individual Cells from Differentially
Treated Populations. Anal. Chem. 2007, 79, 3554−3560.
(19) Kleinfeld, A. M.; Kampf, J. P.; Lechene, C. Transport of 13C-
Oleate in Adipocytes Measured Using Multi Imaging Mass
Spectrometry. J. Am. Soc. Mass Spectrom. 2004, 15, 1572−1580.
(20) He, C.; Fong, L. G.; Young, S. G.; Jiang, H. NanoSIMS
Imaging: An Approach for Visualizing and Quantifying Lipids in Cells
and Tissues. J. Invest. Med. 2017, 65, 669−672.
(21) He, C.; Hu, X.; Jung, R. S.; Weston, T. A.; Sandoval, N. P.;
Tontonoz, P.; Kilburn, M. R.; Fong, L. G.; Young, S. G.; Jiang, H.
High-Resolution Imaging and Quantification of Plasma Membrane
Cholesterol by NanoSIMS. Proc. Natl. Acad. Sci. U. S. A. 2017, 114,
2000−2005.
(22) He, C.; Weston, T. A.; Jung, R. S.; Heizer, P.; Larsson, M.; Hu,
X.; Allan, C. M.; Tontonoz, P.; Reue, K.; Beigneux, A. P.; Ploug, M.;
Holme, A.; Kilburn, M.; Guagliardo, P.; Ford, D. A.; Fong, L. G.;
Young, S. G.; Jiang, H. NanoSIMS Analysis of Intravascular Lipolysis
and Lipid Movement across Capillaries and into Cardiomyocytes. Cell
Metab. 2018, 27, 1055−1066.
(23) Steinhauser, M. L.; Bailey, A. P.; Senyo, S. E.; Guillermier, C.;
Perlstein, T. S.; Gould, A. P.; Lee, R. T.; Lechene, C. P. Multi-Isotope
Imaging Mass Spectrometry Quantifies Stem Cell Division and
Metabolism. Nature 2012, 481, 516−519.
(24) Overington, J. P.; Al-Lazikani, B.; Hopkins, A. L. How Many
Drug Targets Are There? Nat. Rev. Drug Discovery 2006, 5, 993−996.
(25) Davission, M.; Weber, P.; Pett-Ridge, J.; Singer, S. Develop-
ment of Standards for NanoSIMS Analyses of Biological Materials;
LLNL-TR-406039; Lawrence Livermore National Lab (LLNL):
Livermore, CA, USA, 2008.
(26) Wilson, R.; Novak, S. Systematics of Secondary-Ion-Mass
Spectrometry Relative Sensitivity Factors versus Electron Affinity and
Ionization Potential for a Variety of Matrices Determined from
Implanted Standards of More Than 70 Elements. J. Appl. Phys. 1991,
69, 466−474.
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